TRxADE HEALTH, Inc. Common Stock
Compare this stock
MEDS Stock Report Card
$
24%
Performance
Score:
10/100
MEDS returned -41.09% in the last 12 months. Based on SPY's performance of -13.95%, its performance is below average giving it a score of 10 of 100.
Technicals
Score:
36/100
MEDS receives a 35 of 100 based on 14 indicators. 4 are bullish, 8 are bearish.
Earnings
Score:
10/100
MEDS has missed earnings 9 times in the last 20 quarters.
Profit
Score:
22/100
Out of the last 20 quarters, MEDS has had 6 profitable quarters and has increased their profits year over year on 2 of them.
Volatility
Score:
52/100
MEDS has had a higher than average amount of volatility over the last 12 months giving it a score of 52 of 100.
TRxADE HEALTH, Inc. Common Stock Summary
Nasdaq / MEDS
Healthcare
Medical - Pharmaceuticals
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Checkout Similar Companies
MEDS scored poorly on our reportcard. Here are some similar companies and how they performed.
